EE176 Cost-Utility Analysis of Fentanyl Sublingual Formulation in the Treatment of Breakthrough Pain in Adults With Cancer, Already on Opioid Maintenance Therapy for Chronic Cancer Pain in Italy

M Paoletti,A Marcellusi,Fs Mennini

doi:10.1016/j.jval.2022.09.426

EE176 Cost-Utility Analysis of Fentanyl Sublingual Formulation in the Treatment of Breakthrough Pain in Adults With Cancer, Already on Opioid Maintenance Therapy for Chronic Cancer Pain in Italy

M Paoletti, A Marcellusi + Show 1 more

Open Access

https://doi.org/10.1016/j.jval.2022.09.426

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Dec 1, 2022
License type: publisher-specific-oa

Affiliation: University of Rome Tor Vergata

#Treatment Of Breakthrough Pain #Breakthrough Cancer Pain + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The aim of this analysis was to quantify the advantages and the cost-utility of fentanyl sublingual formulation in terms of pain intensity reduction for each episode of breakthrough cancer pain (BTCP) compared to morphine therapy in Italy.

Full Text